MoneyWorks4Me

Kunal Narendra Gandhi submits revised disclosures

13 Apr 2018 Evaluate

The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kunal Narendra Gandhi.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1741.65
Dr. Reddys Labs. 1239.00
Cipla 1325.75
Lupin 1944.90
Zydus Lifesciences 1118.10
View more..